Maneb News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Maneb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Maneb Today - Breaking & Trending Today
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 4,600 shares, a growth of 39.4% from the February 29th total of 3,300 shares. Based on an average trading volume of 8,700 shares, the short-interest ratio […] ....
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 4,600 shares, an increase of 39.4% from the February 29th total of 3,300 shares. Approximately 0.1% of the shares of the company are sold short. Based […] ....
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 31st, there was short interest totalling 2,700 shares, a decline of 18.2% from the January 15th total of 3,300 shares. Approximately 0.1% of the shares of the stock are short sold. Based […] ....
Anebulo Pharmaceuticals (NASDAQ:ANEB – Get Free Report) is scheduled to be announcing its earnings results on Thursday, February 8th. Anebulo Pharmaceuticals (NASDAQ:ANEB – Get Free Report) last announced its quarterly earnings data on Tuesday, November 14th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.01. […] ....
Anebulo Pharmaceuticals (NASDAQ:ANEB – Get Free Report) will announce its earnings results on Wednesday, November 8th. Anebulo Pharmaceuticals (NASDAQ:ANEB – Get Free Report) last announced its quarterly earnings results on Wednesday, September 20th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.10). On average, analysts expect Anebulo […] ....